The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNK.L Regulatory News (DNK)

  • There is currently no data for DNK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total voting rights and capital

4 Feb 2020 07:00

RNS Number : 8234B
Danakali Limited
04 February 2020
 

Announcement

Tuesday, 4 February 2020

 

Total voting rights and capital

 

In accordance with the FCA's Disclosure and Transparency Rule 5.6.1(R), Danakali Limited (ASX: DNK / LSE: DNK) (Danakali, or the Company) confirms that as at 31 January 2020, the Company's issued share capital comprises 318,721,306 ordinary shares of no par value, with each share carrying the right to one vote. The Company does not hold any ordinary shares in treasury.

 

The above figure of 318,721,306 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or of a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

 

 

 

For more information, please contact:

 

Danakali

 

Niels Wage

Chief Executive Officer

+61 8 6189 8635

Todd Romaine

Chief Sustainability Officer

+1 (604) 365 5999

 

Corporate Broker - Numis Securities

 

UK IR/PR - Instinctif Partners

John Prior / James Black / Paul Gillam

+44 (0)20 7260 1000

Mark Garraway / Sarah Hourahane / Dinara Shikhametova

danakali@instinctif.com

+44 (0)207 457 2020

 

 

Announcement authorised for release by the Company Secretary of Danakali.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRKZGGZRFNGGZM
Date   Source Headline
9th Jun 20057:01 amRNSNotice of Results
7th Jun 20052:36 pmRNSHolding(s) in Company
27th May 20051:33 pmRNSTrading Update
19th May 20054:55 pmRNSIssue of Participating Shares
22nd Apr 20055:07 pmRNSBlocklisting Interim Review
8th Apr 20053:28 pmRNSBlocklisting Interim Review
6th Apr 20051:30 pmRNSOrganisational Realignment
18th Feb 20051:30 pmRNSDirectorate Change
17th Feb 20053:30 pmRNSIssue of Participating Shares
8th Feb 20053:36 pmRNSDirector Shareholding
4th Feb 20051:30 pmRNS3rd Quarter Results
31st Jan 20053:06 pmRNSNotice of Q3 Results
19th Jan 20051:30 pmRNSNotice of Investor Conference
17th Jan 20054:30 pmRNSHolding(s) in Company
13th Jan 20051:32 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.